Q32 BIO INC
QTTB · NASDAQ
更新於 2026-10-14 12:52:04
- 今日最高
- $8.69
- 今日最低
- $7.89
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $8.64
- 昨天收盤價
- $8.74
- 成交量
- 684.59K
- 市值
- $260.18M
- 市盈率（P/E）
- 8.81X
- 每股收益（EPS）
- $2.28
昨天價格區間
52週價格區間
公司概況
- 板塊
- HEALTHCARE
- 行業
- Biotechnology
- 子行業
- BIOTECHNOLOGY
- 總部
- 830 WINTER STREET, WALTHAM, MA, UNITED STATES, 02451
- 國家
- US
- 上市日期
- 2018-03-28
- 財年截止
- December
- 流通股數
- 29.76M
- CIK
- 0001661998
- 官方網址
- www.q32bio.com
Q32 Bio Inc. (QTTB) is a pioneering biotechnology firm focused on the development of advanced antibody-based therapies for autoimmune diseases and immune response optimization. Leveraging its proprietary technology platform, the company is building a robust pipeline of therapeutic candidates designed to restore immune balance and tackle significant unmet medical needs. Guided by a seasoned management team and reinforced by strategic collaborations, Q32 Bio is well-positioned to make impactful contributions to healthcare and generate substantial long-term value for its shareholders through dedicated research and development initiatives.
財務指標
營業收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$53.73M
2025-09-30
$0
營業支出
2026-06-30
$9.03M
2026-03-31
$7.72M
2025-12-31
$7.85M
2025-09-30
$7.57M
淨利潤
2026-06-30
-$8.94M
2026-03-31
-$7.6M
2025-12-31
$57.73M
2025-09-30
-$7.38M
淨利潤率
2026-06-30
--
2026-03-31
--
2025-12-31
107.43%
2025-09-30
--
每股收益
2026-06-30
$-0.44
2026-03-31
$-0.54
2025-12-31
$4.58
2025-09-30
$-0.60
息稅折舊攤銷前利潤
2026-06-30
-$8.86M
2026-03-31
-$7.63M
2025-12-31
$58.02M
2025-09-30
-$6.99M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $0 | $0 | $53.73M | $0 |
| 營業支出 | $9.03M | $7.72M | $7.85M | $7.57M |
| 淨利潤 | -$8.94M | -$7.6M | $57.73M | -$7.38M |
| 淨利潤率 | -- | -- | 107.43% | -- |
| 每股收益 | $-0.44 | $-0.54 | $4.58 | $-0.60 |
| 息稅折舊攤銷前利潤 | -$8.86M | -$7.63M | $58.02M | -$6.99M |
| 有效稅率 | -- | -- | -- | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。